![决明子总蒽醌对小鼠免疫性肝损伤保护作用的实验研究_第1页](http://file4.renrendoc.com/view14/M01/23/2A/wKhkGWZA_b2AYHVVAAMvgK2BKOM394.jpg)
![决明子总蒽醌对小鼠免疫性肝损伤保护作用的实验研究_第2页](http://file4.renrendoc.com/view14/M01/23/2A/wKhkGWZA_b2AYHVVAAMvgK2BKOM3942.jpg)
![决明子总蒽醌对小鼠免疫性肝损伤保护作用的实验研究_第3页](http://file4.renrendoc.com/view14/M01/23/2A/wKhkGWZA_b2AYHVVAAMvgK2BKOM3943.jpg)
![决明子总蒽醌对小鼠免疫性肝损伤保护作用的实验研究_第4页](http://file4.renrendoc.com/view14/M01/23/2A/wKhkGWZA_b2AYHVVAAMvgK2BKOM3944.jpg)
![决明子总蒽醌对小鼠免疫性肝损伤保护作用的实验研究_第5页](http://file4.renrendoc.com/view14/M01/23/2A/wKhkGWZA_b2AYHVVAAMvgK2BKOM3945.jpg)
版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
决明子总蒽醌对小鼠免疫性肝损伤保护作用的实验研究Title:ExperimentalStudyontheHepatoprotectiveEffectsofCassiaSeedAnthraquinonesonImmune-MediatedLiverInjuryinMiceAbstract:Objective:Thisstudyaimedtoinvestigatethepotentialhepatoprotectiveeffectsofcassiaseedanthraquinones(CSAs)againstimmune-mediatedliverinjuryinmice.Methods:Thirty-twomaleC57BL/6micewererandomlydividedintofourgroups:controlgroup,modelgroup,low-doseCSAsgroup,andhigh-doseCSAsgroup.ThemiceinthemodelandtreatmentgroupswereintraperitoneallyinjectedwithconcanavalinA(ConA)toinduceimmune-mediatedliverinjury.TheCSAsgroupsreceivedCSAsatdosesof50and100mg/kg,respectively.Hepaticfunctionmarkers,pro-inflammatorycytokines,oxidativestressparameters,histopathologicalchanges,andimmunecellinfiltrationwereevaluated.Results:Comparedwiththemodelgroup,theCSAsgroupsshowedsignificantreductionsinthelevelsofserumalanineaminotransferase(ALT),aspartateaminotransferase(AST),andtotalbilirubin(TBIL).Additionally,CSAstreatmentresultedindecreasedhepaticlevelsoftumornecrosisfactor-alpha(TNF-α),interleukin-6(IL-6),andinterferon-gamma(IFN-γ),indicatingitsanti-inflammatoryeffect.CSAsalsoattenuatedoxidativestressbyrestoringthebalanceofantioxidantenzymesandreducinglipidperoxidation.Histopathologicalanalysisrevealedareductioninhepatocellularnecrosis,inflammatorycellinfiltration,andhepaticfibrosisintheCSAsgroupscomparedtothemodelgroup.Moreover,CSAstreatmentsignificantlysuppressedtheactivationofTlymphocytesanddecreasedtheinfiltrationofnaturalkiller(NK)cellsintheliver.Conclusion:OurstudydemonstratedthatCSAsexertprotectiveeffectsagainstimmune-mediatedliverinjuryinmice.Theseeffectsmaybeattributedtotheirabilitytoreducehepatocellulardamage,suppressinflammation,attenuateoxidativestress,andmodulateimmunecellresponse.FurtherresearchiswarrantedtoexploretheunderlyingmechanismsandclinicalpotentialofCSAsasatherapeuticagentforimmune-mediatedliverdiseases.Keywords:Cassiaseedanthraquinones,immune-mediatedliverinjury,hepatoprotection,inflammation,oxidativestress,immuneresponse,miceIntroduction:Immune-mediatedliverinjuryencompassesaspectrumofdisorderscharacterizedbydysregulatedimmuneresponsestargetinghepatictissues.Variousetiologicalfactors,includingviralinfection,autoimmunity,drugtoxicity,andmetabolicdisorders,cantriggerimmune-mediatedliverdamage(1).Hepatitis,hepatocellularnecrosis,cholestasis,andhepaticfibrosisarecommonhistopathologicalfeaturesofimmune-mediatedliverinjury,withinflammationplayingacentralroleindiseaseprogression(2).Althoughseveraltherapeuticoptionsareavailableforimmune-mediatedliverdiseases,theirefficacyandsafetyprofilesremainlimited(3).Therefore,theexplorationofnoveltherapeuticagentswithhepatoprotectiveandimmunomodulatorypropertiesisofgreatsignificance.Cassiaseeds,derivedfromthematurefruitsofCassiaobtusifoliaorCassiatoraplants,havebeenwidelyusedintraditionalChinesemedicineforcenturies.Theseseedscontainabundantbioactivecompounds,includingcassiaseedanthraquinones(CSAs),whichpossessmultiplepharmacologicalactivities,suchasanti-inflammatory,antioxidant,andimmunomodulatoryeffects(4,5).CSAshavebeenshowntoexerthepatoprotectiveeffectsinvariousliverdiseases,includingdrug-inducedliverinjury,non-alcoholicfattyliverdisease,andliverfibrosis(6,7).However,thepotentialeffectsofCSAsonimmune-mediatedliverinjuryandtheunderlyingmechanismsremainlargelyunexplored.Inthisstudy,weaimedtoinvestigatethepossibleprotectiveeffectsofCSAsagainstimmune-mediatedliverinjuryusingaconcanavalinA(ConA)-inducedmousemodel.ConA,aplant-derivedlectin,isawidelyusedinducerofimmune-mediatedhepatitis,mimickingsomeaspectsofautoimmunehepatitis(8,9).Weevaluatedthehepaticfunction,pro-inflammatorycytokines,oxidativestressparameters,histopathologicalchanges,andimmunecellinfiltrationtoassessthepotentialhepatoprotectiveeffectsofCSAsinthismodel.MaterialsandMethods:Animals:Thirty-twomaleC57BL/6mice,aged6-8weeks,weighing20-25g,wereobtainedfromtheAnimalExperimentalCenterofourinstitution.Themicewerehousedunderstandardlaboratoryconditions,witha12-hlight/darkcycleandadlibitumaccesstofoodandwater.AllanimalprocedureswereconductedaccordingtotheguidelinesoftheAnimalCareandUseCommitteeofourinstitution.ConA-inducedimmune-mediatedliverinjurymodelandtreatmentprotocol:Themicewererandomlydividedintofourgroups(n=8pergroup):controlgroup,modelgroup,low-doseCSAsgroup,andhigh-doseCSAsgroup.ThemiceinthemodelandtreatmentgroupswereinjectedviathetailveinwithasingledoseofConA(20mg/kgbodyweight)toinduceimmune-mediatedliverinjury.Thecontrolgroupreceivedanequivalentvolumeofsterilesaline.ThirtyminutesafterConAinjection,theCSAsgroupswereorallyadministeredCSAsatdosesof50mg/kg(low-dosegroup)and100mg/kg(high-dosegroup),respectively,whilethecontrolandmodelgroupsreceivedanequivalentvolumeofvehicle(distilledwater).CSAsweredissolvedindistilledwaterandpreparedimmediatelybeforeuse.ThetreatmentwithCSAswascontinuedoncedailyforfiveconsecutivedays.Themiceweresacrificed24hafterConAinjection,andbloodandliversampleswerecollectedforfurtheranalysis.Hepaticfunctionmarkersanalysis:Theserumlevelsofalanineaminotransferase(ALT),aspartateaminotransferase(AST),andtotalbilirubin(TBIL)weremeasuredusingcommercialkitsaccordingtothemanufacturer'sinstructions.Pro-inflammatorycytokineanalysis:Thelevelsoftumornecrosisfactor-alpha(TNF-α),interleukin-6(IL-6),andinterferon-gamma(IFN-γ)intheliversupernatantsweredeterminedusingenzyme-linkedimmunosorbentassay(ELISA)kits.Oxidativestressparametersanalysis:Thelevelsofmalondialdehyde(MDA),superoxidedismutase(SOD),andglutathioneperoxidase(GSH-Px)inthelivertissuewereassessedusingcommerciallyavailableassaykits.Histopathologicalevaluation:Livertissueswerefixedin10%bufferedformalin,embeddedinparaffin,andsectionedinto4-μm-thickslices.Hematoxylinandeosin(H&E)stainingwasperformedtoevaluatethedegreeofhepatocellularnecrosis,inflammatorycellinfiltration,andhepaticfibrosis.Immunecellanalysis:TheinfiltrationofTlymphocytesandnaturalkiller(NK)cellsinthelivertissuewasexaminedbyimmunohistochemistryusingspecificantibodiesagainstCD3andNK1.1,respectively.Statisticalanalysis:Dataarepresentedasmean±standarddeviation(SD)andwereanalyzedusingtheSPSSstatisticalsoftware.One-wayanalysisofvariance(ANOVA)followedbyTukey'sposthoctestwasemployedtodeterminethestatisticalsignificanceamonggroups.P-valueslessthan0.05wereconsideredstatisticallysignificant.Results:EffectofCSAsonhepaticfunctionmarkers:AsshowninFigure1,thelevelsofALT,AST,andTBILinthemodelgroupweresignificantlyhigherthanthoseinthecontrolgroup,indicatinghepaticdysfunction.TreatmentwithCSAs,especiallyatthehighdose,significantlyreducedtheelevationofhepaticfunctionmarkerscomparedtothemodelgroup(P<0.05forALT,AST,andTBIL).EffectsofCSAsonpro-inflammatorycytokines:ELISAresultsrevealedthatthehepaticlevelsofTNF-α,IL-6,andIFN-γinthemodelgroupweresignificantlyincreasedcomparedwiththecontrolgroup(Figure2).However,treatmentwithCSAssignificantlyreducedthelevelsofthesepro-inflammatorycytokines,implyingthatCSAspossesspotentanti-inflammatoryeffectsinimmune-mediatedliverinjury.EffectsofCSAsonoxidativestressparameters:Oxidativestressiscloselyassociatedwithimmune-mediatedliverinjury.AsshowninFigure3,thelevelofMDA,anoxidativestressmarker,wassignificantlyelevatedinthemodelgroup,whiletheactivitiesofSODandGSH-Pxweresignificantlydecreasedcomparedtothecontrolgroup.TreatmentwithCSAseffectivelyrestoredthehepaticlevelsofMDA,SOD,andGSH-Px,indicatingtheirantioxidanteffectsinimmune-mediatedliverinjury.Histopathologicalchanges:H&Estainingshowedthatlivertissuesfromthecontrolgrouphadanormalhepaticarchitecture,withwell-preservedhepatocytesandminimalinflammatorycellinfiltration(Figure4A).Incontrast,theliversectionsfromthemodelgroupdemonstratedextensivehepatocellularnecrosis,inflammatorycellinfiltration,andhepaticfibrosis.However,treatmentwithCSAsresultedinmarkedimprovementsinhistopathologicalalterations,includingdecreasednecrosis,fewerinfiltratinginflammatorycells,andreducedfibrosisscore(Figure4B).Immunecellinfiltration:ImmunohistochemicalstainingrevealedasignificantincreaseintheinfiltrationofCD3-positiveTlymphocytesandNK1.1-positiveNKcellsinthemodelgroupcomparedtothecontrolgroup(Figure5).Notably,treatmentwithCSAsledtoasignificantreductionintheinfiltrationofbothTlymphocytesandNKcellsinthelivertissue,suggestingtheirimmunomodulatoryeffects.Discussion:Immune-mediatedliverinjury,characterizedbyhepatocytedamage,inflammation,oxidativestress,anddysregulatedimmuneresponses,remainsatherapeuticchallenge.Naturalproductswithhepatoprotectiveandimmunomodulatorypropertieshavegainedincreasedattentionaspotentialtherapeuticagentsforliverdiseases.Inthisstudy,weinvestigatedthehepatoprotectiveeffectsofCSAsonimmune-mediatedliverinjuryusingaConA-inducedmousemodel.OurresultsshowedthatCSAseffectivelyattenuatedimmune-mediatedliverinjury,asevidencedbythesignificantreductionsinhepaticfunctionmarkers(ALT,AST,andTBIL)intheCSAs-treatedgroups.ThesefindingsindicatetheabilityofCSAstorestorehepaticfunctionandprotectagainsthepatocellulardamage.LiverinjurytriggeredbyConAadministrationisprimarilymediatedbyactivatedTlymphocytes,leadingtothereleaseofnumerouspro-inflammatorycytokines(10).Inourstudy,CSAstreatmentmarkedlydecreasedthehepaticlevelsofTNF-α,IL-6,andIFN-γ,suggestingtheiranti-inflammatoryeffects.Overproductionofthesepro-inflammatorycytokinesexacerbatesliverdamagebyinducinghepatocellularapoptosis,enhancingcelladhesion,andrecruitinginflammatorycells(11).Bysuppressingtheproductionofpro-inflammatorycytokines,CSAsmayinhibittheinflammatorycascadeandsubsequentlyalleviateimmune-mediatedliverinjury.Oxidativestressiscloselyrelatedtothepathogenesisofimmune-mediatedliverinjury,asexcessiveproductionofreactiveoxygenspecies(ROS)canleadtolipidperoxidation,DNAdamage,andcelldeath(12).CSAshavebeenreportedtoexhibitpotentantioxidantactivities(13).Inourstudy,CSAstreatmentrestoredthebalanceofantioxidantenzymes(SODandGSH-Px)anddecreasedlipidperoxidation(MDAlevel),suggestingtheirabilitytoscavengefreeradicalsandattenuateoxidativestressinthelivertissue.Histopathologicalchangesandimmunecellinfiltrationinthelivertissuereflecttheseverityofliverinjuryandtheextentoftheimmuneresponse.Inthisstudy,CSAstreatmenteffectivelyamelioratedhepatocellularnecrosis,inflammatorycellinfiltration,andhepaticfibrosis,asobservedinH&E-stainedliversections.Thisisconsistentwithpreviousfindingsdemonstratingtheanti-fibroticeffectsofCSAsinliverdiseases(7).ImmunohistochemicalanalysisfurtherrevealedthatCSAstreatmentsignificantlyreducedtheinfiltrationofTlymphocytesandNKcellsinthelivertissue.Excessiveactivationandinfiltrationofimmunecellsplaycriticalrolesinimmune-mediatedliverinjury,leadingtotissuedamageandperpetuationoftheinflammatoryresponse(11).TheobservedreductioninimmunecellinfiltrationsuggeststhatCSAsmaymodulateimmunecellresponsesandres
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2024-2030年中国废品回收行业发展分析及发展前景与趋势预测研究报告
- 2024-2030年中国帆船风衣行业市场发展趋势与前景展望战略分析报告
- 2024-2030年中国布地奈德喷雾剂行业市场发展趋势与前景展望战略分析报告
- 2024-2030年中国工程机械行业发展态势及应用前景预测报告
- 2024-2030年中国工控计算机行业运行趋势及投资前景展望报告
- 2024-2030年中国工业级芳纶蜂窝芯行业运行态势与需求趋势预测报告
- 建筑装饰行业建议书
- WD的基础知识和基本操作培训材料
- 2024版全新标准互联网服务合同
- 考古遗迹发掘行业市场突围建议书
- 中国耐碱玻璃纤维行业市场现状供需分析及市场深度研究发展前景及规划可行性分析研究报告(2024-2030)
- 广东省广州市2023-2024学年一年级下学期期末数学试卷
- 国开2024年《建筑结构#》形考作业1-4答案
- DL-T1475-2015电力安全工器具配置与存放技术要求
- 澳大利亚11天自由行行程单英文版
- 部编人教版五年级数学上册《第1单元-小数乘法【全单元】》优质课件
- (完整)注册安全工程师考试题库及答案(通用版)
- YY∕T 1796-2021 医用干式胶片专用技术条件
- 产学研合作项目协议书
- 《建筑工程设计资质分级标准》(建设[1999]9号文)
- 投资回收期估算表
评论
0/150
提交评论